巨细胞病毒或改进黑色素瘤疗效

Core Viewpoint - A new study led by scientists from the University of Oxford suggests that the common and usually harmless cytomegalovirus (CMV) may help improve the treatment efficacy of melanoma, providing new insights for cancer immunotherapy [1] Group 1 - The research indicates a potential role of CMV in enhancing melanoma treatment outcomes [1] - The findings were published in the latest issue of the journal Nature Medicine, highlighting the significance of the study in the field of cancer research [1]